BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32900632)

  • 1. Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma.
    Otsuka H; Uemura K; Kondo N; Sumiyoshi T; Nakagawa N; Okada K; Seo S; Murakami Y; Takahashi S
    Pancreatology; 2020 Oct; 20(7):1472-1478. PubMed ID: 32900632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of recurrence pattern after resection for pancreatic cancer.
    Tanaka M; Mihaljevic AL; Probst P; Heckler M; Klaiber U; Heger U; Büchler MW; Hackert T
    Br J Surg; 2019 Nov; 106(12):1590-1601. PubMed ID: 31454073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.
    Thomas RM; Truty MJ; Nogueras-Gonzalez GM; Fleming JB; Vauthey JN; Pisters PW; Lee JE; Rice DC; Hofstetter WL; Wolff RA; Varadhachary GR; Wang H; Katz MH
    J Gastrointest Surg; 2012 Sep; 16(9):1696-704. PubMed ID: 22644446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival.
    Groot VP; Blair AB; Gemenetzis G; Ding D; Burkhart RA; van Oosten AF; Molenaar IQ; Cameron JL; Weiss MJ; Yang SC; Wolfgang CL; He J
    HPB (Oxford); 2019 Aug; 21(8):998-1008. PubMed ID: 30777697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
    Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
    World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma.
    Yamashita K; Miyamoto A; Hama N; Asaoka T; Maeda S; Omiya H; Takami K; Doki Y; Mori M; Nakamori S
    Dig Surg; 2015; 32(6):464-71. PubMed ID: 26517228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas.
    Downs-Canner S; Zenati M; Boone BA; Varley PR; Steve J; Hogg ME; Zureikat A; Zeh HJ; Lee KK
    J Surg Oncol; 2015 Jul; 112(1):80-5. PubMed ID: 26153355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma.
    Asakura Y; Toyama H; Ishida J; Asari S; Terai S; Shirakawa S; Yamashita H; Shimizu T; Ogura Y; Matsumoto I; Gon H; Tsugawa D; Komatsu S; Kuramitsu K; Yanagimoto H; Kido M; Ajiki T; Fukumoto T
    Asian J Surg; 2023 Jan; 46(1):207-212. PubMed ID: 35370072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?
    Miyazaki M; Yoshitomi H; Shimizu H; Ohtsuka M; Yoshidome H; Furukawa K; Takayasiki T; Kuboki S; Okamura D; Suzuki D; Nakajima M
    Surgery; 2014 Jan; 155(1):58-66. PubMed ID: 24238124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns.
    Wangjam T; Zhang Z; Zhou XC; Lyer L; Faisal F; Soares KC; Fishman E; Hruban RH; Herman JM; Laheru D; Weiss M; Li M; De Jesus-Acosta A; Wolfgang CL; Zheng L
    Oncotarget; 2015 Nov; 6(34):36903-10. PubMed ID: 26372811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
    Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
    World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
    Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis.
    Homma Y; Endo I; Matsuyama R; Sho M; Mizuno S; Seyama Y; Hirano S; Aono T; Kitami C; Morita Y; Takeda Y; Yoshida K; Tani M; Kaiho T; Yamamoto Y; Aoki H; Ogawa M; Niguma T; Mataki Y; Kawasaki H; Baba H; Yokomizo H; Rikiyama T; Yamaue H; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2022 May; 29(5):552-561. PubMed ID: 35179827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
    Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical resection for liver recurrence after curative resection of pancreatic ductal adenocarcinoma.
    Shibata Y; Uemura K; Sumiyoshi T; Okada K; Otsuka H; Serikawa M; Ishii Y; Murakami Y; Arihiro K; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):280. PubMed ID: 37458812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.